Pages

Tuesday, December 20, 2011

Genmab Announces Progress With DuoBody(TM) Platform

DuoBody-ADC Research Collaboration With Undisclosed Pharma Company COPENHAGEN, Denmark, Dec. 20, 2011 (GLOBE NEWSWIRE) -- Genmab A/S (Copenhagen:GEN) announced today that the company has entered a research collaboration with an as yet undisclosed, new large pharmaceutical partner to investigate a bispecific antibody-drug conjugate using Genmab's DuoBody technology in combination with a novel antibody-drug conjugate technology platform from the pharma company. If successful, the parties may decid...continued
  

No comments:

Post a Comment